FUND COMMENTARY THREADNEEDLE UK MID 250 FUND
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
COVERING FEBRUARY 2021
FUND COMMENTARY
THREADNEEDLE UK MID 250 FUND
Summary
UK mid-cap stocks performed well in February.
Gross of fees, the fund modestly underperformed its benchmark – the FTSE
250 ex-IT (ICB) index – over the month.
Much of the underperformance was due to the absence of some strong
performers, such as Virgin Money, easyJet and TUI.
Outperformers included Cineworld and SSP.
We participated in the initial public offerings (IPOs) of Moonpig and Auction
James Thorne
Technology.
Co-Fund Manager
Market Background
The FTSE 250 ex-IT (ICB) index returned 4.6% in February, outperforming the
FTSE All-Share, which was up 1.9%.
UK equities were boosted by optimism around the successful roll-out of the
country’s vaccination programme, with around 20 million people having received
their first doses by the end of the month. Together with falling Covid-19 cases in
the UK, this raised expectations of a return to ‘normality’ by mid-summer, and
hence, a swifter economic recovery. However, global markets swold off later in
the month as bond yields rose on worries that a rebound in the world economy
Craig Adey may increase inflation and thereby lead to central banks reining in their
Co-Fund Manager accommodative measures.
The prospects for economic reopening helped to lift the pound, as did indications
that the Bank of England would be unlikely to adopt negative interest rates in the
near future. The currency’s rise was a further boost for UK small caps.
On the economic front, the UK’s GDP rose by a stronger-than-expected 1% in Q4.
For 2020 as a whole, however, GDP was down by a record 9.9%, as repeated
lockdowns and other restrictions took their toll on the economy. Meanwhile, UK
inflation moved slightly higher in January, and some economists predicted that it
would exceed the Bank of England’s 2% target later in 2021. More positively, the
composite purchasing managers’ index rebounded to the verge of expansionary
territory in February, reflecting optimism about the potential for a recovery.
Consumer sentiment also improved during the month, rising to its highest since
last March as measured by an index compiled by GfK.
Performance
Gross of fees, the fund returned 4.4% in February and modestly underperformed
the FTSE 250 ex-IT (ICB) index.
Much of the underperformance was due to the absence of some strong
performers. Examples included Virgin Money, easyJet and TUI. Virgin Money
reported a quarterly profit for the first time in three years, while easyJet and TUI
benefited from hopes that vaccines would spur a recovery in travel and tourism.
FOR INVESTMENT PROFESSIONAL USE ONLY 1 Issued March 2021 | Valid to end June 2021
FUND COMMENTARY | FEBRUARY 2021 The holding in S4 was unhelpful too. Following a period of strong returns, the stock underperformed owing to the wider market rotation out of quality growth. Nevertheless, our investment thesis remains intact. S4 is making selected acquisitions and its slender cost base enables the firm to offer its services at much lower prices than the big-name traditional players. Positive contributors included Cineworld, SSP and Future. Cineworld and SSP benefited from vaccine- related optimism. Future’s management announced that profits for its current fiscal year could be well ahead of forecasts. The company also expressed optimism about its integration of TI Media – acquired last April – and has now completed the acquisition of GoCo. Future is strengthening its presence in e-commerce and also progressing well in transitioning from print to digital media. Our new position in online card and gift retailer Moonpig also added value; shares surged following its successful IPO. Activity We participated in the IPOs of Moonpig and Auction Technology Group. Moonpig has a dominant presence in the UK and the Netherlands. The business has reached an inflection point; we believe that growth can now accelerate due to technology and the leveraging of marketing costs. Moonpig is an exceptionally high-return business with very little demand on capital. Auction Technology offers a well-invested marketplace technology platform for auctions across both the industrial and collectables sectors. The company is expanding its global presence and is also benefiting from the ongoing shift to online auctions that has accelerated as a result of Covid-19. We also initiated a position in market research and data analytics firm YouGov. We have monitored the stock for a long time, when it was in the small-cap space; the market cap now exceeds £1bn. YouGov’s consumer data and market-research platform continues to gain scale globally, and we are excited by new data product launches and the growing customer pipeline. The stock’s de-rating, amid a rotation away from these names over the last six months, provided an attractive entry point. We continued to build our holdings in Jet2 and HomeServe, which were added to the portfolio in January. . We sold AFH Financial ahead of the company’s takeover. We also exited Vistry. Outlook While the immediate economic outlook associated with renewed lockdowns has deteriorated somewhat, the announcement of a number of vaccines has buoyed hopes of a swifter economic recovery. Meanwhile, the Brexit deal should remove a large part of the uncertainty that has weighed on UK equities in recent years. That said, we expect the return to pre-crisis rates of growth to be slow. In particular, there are headwinds for the consumption sector, a significant contributor to the UK’s GDP, while Brexit is still likely to result in some frictional trade costs. Nevertheless, we believe there are positive drivers for small caps. High-quality businesses are likely to emerge from the crisis even stronger. We also see attractive prospects for businesses perceived to have too much debt at a headline level, but which have strong liquidity and the ability to cut costs. Finally, we feel that the share prices of certain companies seem to be discounting significant future equity raising. We are monitoring companies closely, and rigorously adhering to our philosophy and process to seek out favoured stocks. FOR INVESTMENT PROFESSIONAL USE ONLY 2 Issued March 2021 | Valid to end June 2021
FUND COMMENTARY | FEBRUARY 2021
Important information
For use by professional clients and/or equivalent investor types in your jurisdiction (not to be used with or passed on to retail clients)
This is an advertising document.
Past performance is not a guide to future performance. The value of investments and any income is not guaranteed and can go down as well as up and
may be affected by exchange rate fluctuations. This means that an investor may not get back the amount invested. Your capital is at risk.
This material is for information only and does not constitute an offer or solicitation of an order to buy or sell any securities or other financial instruments, or
to provide investment advice or services. The mention of any specific shares or bonds should not be taken as a recommendation to deal.
Threadneedle Specialist Investment Funds ICVC (“TSIF”) is an open-ended investment company structured as an umbrella company, incorporated in
England and Wales, authorised and regulated in the UK by the Financial Conduct Authority (FCA) as a Non- UCITS scheme.
Subscriptions to a Fund may only be made on the basis of the current Prospectus and the Key Investor Information Document, as well as the latest annual
or interim reports and the applicable terms & conditions. Please refer to the ‘Risk Factors’ section of the Prospectus for all risks applicable to investing in
any fund and specifically this Fund. The above documents are available in English only and may be obtained free of charge on request from Columbia
Threadneedle Investments at PO Box 10033, Chelmsford, Essex CM99 2AL
For Swiss investors: Subscriptions to a Fund may only be made on the basis of the current Prospectus and the Key Investor Information Document, as well
as the latest annual or interim reports and the applicable terms & conditions. Please refer to the ‘Risk Factors’ section of the Prospectus for all risks
applicable to investing in any fund and specifically this Fund. The above documents and the instrument of incorporation are available on request from our
representative and Paying Agent in Switzerland, BNP Paribas Securities Services, Paris, succursale de Zurich, Selnaustrasse 16,CH-8002 Zurich.
Shares in the Funds may not be offered, sold or delivered directly or indirectly in the United States or to or for the account or benefit of any “U.S. Person”,
as defined in Regulation S under the 1933 Act.
The analysis included in this document has been produced by Columbia Threadneedle Investments for its own investment management activities, may
have been acted upon prior to publication and is made available here incidentally. Any opinions expressed are made as at the date of publication but are
subject to change without notice and should not be seen as investment advice. Information obtained from external sources is believed to be reliable but its
accuracy or completeness cannot be guaranteed.
Issued by Threadneedle Investment Services Limited. Registered in England and Wales, Registered No. 3701768, Cannon Place, 78 Cannon Street
London EC4N 6AG, United Kingdom. Authorised and regulated in the UK by the Financial Conduct Authority.
Columbia Threadneedle Investments is the global brand name of the Columbia and Threadneedle group of companies.
Benchmark Index is the FTSE 250 (ex IT). Performance attribution source FactSet, calculated using a daily time-weighted methodology based on gross
returns as at global close on the last working day of the month.
columbiathreadneedle.com
FOR INVESTMENT PROFESSIONAL USE ONLY 2 Issued March 2021 | Valid to end June 2021You can also read
